Unique Pharmaceutical Laboratories Recalls Cetirizine Hydrochloride Due to Ranitidine Contamination
Unique Pharmaceutical Laboratories is recalling four lots of Cetirizine Hydrochloride Tablets due to cross contamination with Ranitidine.
Asset / Drug
Drug and asset intelligence for Ranitidine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.